Jazz Pharmaceuticals JAZZ Gain (Loss) on Disposition of Other Assets
Gain (Loss) on Disposition of Other Assets at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfOtherAssets.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's gain (loss) on disposition of other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's gain (loss) on disposition of other assets?
- Jazz Pharmaceuticals (JAZZ) reported gain (loss) on disposition of other assets of $122.8M in Q1 2026.